Companies research board

Displaying 701 - 800 of 1172

Developer of personalized cancer treatments.


A life science company exploring how modified mRNA will create a new class of drugs, native protein therapeutics.


Novel technologies company for immunodiagnostics.


Manufacturer of Sodium Borohydride (NaBH4) in North America.


Biotechnology company focused on the generation of proprietary organisms for product discovery and development.


Provider of bioresponsive materials for tissue regeneration


Developer of intradermal drug delivery technologies and novel drug/device therapies.


Nanopoint, Inc. is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.


A nanotechnology-based molecular diagnostics company.


Biotechnology company providing preconception and prenatal genetic testing services.


A therapeutics company focusing on discoveries in the areas of Cancer and Metastatic disease (secondary cancer).


Biotech company focused on developing antibody-based treatments for cancer patients.


A biotechnology company


Medical devices utilizing a proprietary, non-invasive technology.


NephroGenex is developing a product to slow the progression of diabetic nephropathy.


(MBM Technologies Inc)


Utilises an established polycaprolactone polymer to construct a tube which holds severed nerve ends together.


A science-based health care company improving patient care through neurotechnology.


(Neurotech Inc)
Cell-based drugs for diseases of the eye.


With the advent of genomics, NCE developed targeted libraries of potential pharmaceutical compounds, geared toward protein interactions.


Health care imaging solution company.


Innovative next generation neurovascular devices.


Biopharmaceutical company focused on the discovery and development of breakthrough therapeutics for metabolic diseases.


Specialty biopharmaceutical company that focuses on developing therapeutics to address clinical unmet needs in reproductive medicine.


NormOxys, Inc., is a biopharmaceutical company.


Developing an in-vitro assay to monitor the activity level of a tumor’s signaling pathways before and after drug administration to assess the response


Maximizing the Therapeutic Impact in Most Common Cancers


Biotechnology company that develop treatment for arthritis, cardiovascular disease, stroke, and cancer.


An antiviral drug discovery company launched in 2009


Stem cell engineering company.


Provider of genomic services.


Provider of genomics sample preparation solutions.


Nutritional bioscience company.


Developer of a drugs for the treatment of hemophilia and genetic disorders of the clotting process.


A diagnostic company, engages in developing non-invasive diagnostic monitoring tools for use in the treatment of individual cancer patients.


A biopharmaceutical company committed to the development and commercialization of new cancer therapies.


Provider of technology dedicated to revolutionizing screening and diagnostics of cervical cancer and other HPV-associated cancers.


Biotechnology company focused on scientific discoveries of cancer stem cells in solid tumors.


Operator of a full service drug and pain testing laboratory receiving specimens from throughout the U.S. and several foreign countries.


A biotechnology company that aims to use developmental biology insights for regenerative medicine therapies.


Whole-cell allogenic vaccines for cancer. Acquired by VaxOnco Inc.


Open Biosystems, Inc. develops, manufactures and markets genomic research tools to scientists and researchers.


Builds the first platform for generating human monoclonal antibodies using a transgenic rat.


Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets.


Commercialization of veterinary vaccine technologies from universities.


Genome wide product company for research and diagnostic applications


Early stage biotechnology company working on a diagnostic for melanoma.


Biomaterials company which has developed a new generation of synthetic bone graft substitute


French AI startup focused on material sciences R&D.